IGI Logo

Shilpa Medicare is currently trading at Rs. 391.40, up by 5.75 points or 1.49% from its previous closing of Rs. 385.65 on the BSE.

The scrip opened at Rs. 387.50 and has touched a high and low of Rs. 399.05 and Rs. 387.50 respectively. So far 8977 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 657.95 on 14-Oct-2021 and a 52 week low of Rs. 367.20 on 29-Aug-2022.

Last one week high and low of the scrip stood at Rs. 399.05 and Rs. 372.75 respectively. The current market cap of the company is Rs. 3411.75 crore.

The promoters holding in the company stood at 50.01%, while Institutions and Non-Institutions held 16.40% and 33.59% respectively.

Shilpa Medicare’s Analytical Services division situated at Nacharam, Hyderabad, Telangana has received United States Food and Drug Administration (USFDA) clearance (EIR) for the inspection performed during April 26 2022 to April 29, 2022. This is the first USFDA inspection of this facility. The facility is identified as testing laboratory in numerous ANDAs filed by Shilpa Medicare and its agreed parties.

The FDA clearance on the facility will enable the company to test and release batches into US from this facility. This facility, after appropriate submissions, can also be used for testing and releasing batches into Europe and other markets of the world. The facility is involved in analytical testing of drug products (Release & Stability), drug substances, raw materials & packing materials. It is also engaged in analytical method validations, method transfers and conduct of other miscellaneous analytical studies.

Shilpa Medicare produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.